New program aims to stop dangerous low blood sugar in diabetes patients
NCT ID NCT06353217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested a new program to help prevent low blood sugar (hypoglycemia) in people with diabetes who take medications that can cause it. The program included a patient survey and a toolkit for doctors. The study involved 35 patients and their primary care providers at one clinic. The main goal was to see if the program was acceptable and practical for use in a busy primary care setting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hypoglycemia Prevention Program (patient survey and provider toolkit)
What this could lead to
If this program works well, it could lead to a larger study and eventually a simple way for doctors to help patients avoid dangerous low blood sugar episodes.
What could go wrong
This is a very small pilot study with only 35 people, so results may not apply to everyone. It focuses on whether the program is acceptable, not yet on whether it actually prevents low blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287, United States